Article Details
Retrieved on: 2022-04-11 21:00:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Announcing early clinical results from an ongoing Phase 1/2 trial, BioNTech (BNTX) said on Monday that its CAR-T cell therapy candidate, ...
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here